课题基金 / 基金详情

Development of Enzyme Replacement Therapy for Urea Cycle Defects

Development of Enzyme Replacement Therapy for Urea Cycle Defects
针对尿素循环缺陷的酶替代疗法的开发
批准号：
173692
负责人：
Campeau Philippe M
金额：
$13.66万
依托单位：
Baylor College of Medicine (Texas)
依托单位国家：
加拿大
项目类别：
Fellowship Programs
财政年份：
2008
资助国家：
加拿大
项目状态：
已结题
起止时间：
2008-09-01 至 2011-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=173692&lang=en
关键词：
Enzyme Replacement Therapy Genetic Disorders Inborn Errors Of Metabolism Protein Transduction Urea Cycle Defects

项目摘要

项目成果

Campeau Philippe M的其他基金

相似基金

相关文献

中文摘要
翻译
尿素循环缺陷(UCDs)是一种常见的遗传性疾病，影响多达8200名儿童，而且非常难以治疗，会导致严重的神经系统疾病和过早死亡。迫切需要新的治疗方法。基因治疗很有前途，但问题是
英文摘要
Urea cycle defects (UCDs) are frequent genetic disorders, affecting up to 1/8200 children, and are notably difficult to treat, causing severe neurologic disease and early death. Novel therapies are urgently needed. Gene therapy is promising, but issues li
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developmental Trajectories in ARID1B-Related Disorders - a Multi-Method Multi-Site Prospective Natural History Study
Identifying and understanding a new skeletal dysplasia caused by ERI1 mutations
Role of fibronectin mutations in spondylometaphyseal dysplasia and idiopathic scoliosis.
Genetic bone diseases; new genes and new treatments
海外基金